132.64

2.24% 2.94

Abbott Laboratories (ABT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$129.70

Aprire:

$130.375

Volume 24 ore:

4.94M

Relative Volume:

0.70

Capitalizzazione di mercato:

$221.92B

Reddito:

$41.95B

Utile/perdita netta:

$13.40B

Rapporto P/E:

17.34

EPS:

7.65

Flusso di cassa netto:

$6.35B

1 W Prestazione:

+6.51%

1M Prestazione:

+3.89%

6M Prestazione:

+12.49%

1 anno Prestazione:

+25.22%

Intervallo 1D:

$129.66

$132.68

Intervallo di 1 settimana:

$124.04

$134.16

Portata 52W:

$99.71

$140.84

Abbott Laboratories Stock (ABT) Company Profile

Nome

Abbott Laboratories

Settore

Healthcare (1156)

Industria

Medical Devices (158)

Telefono

(224) 667-6100

Indirizzo

100 ABBOTT PARK ROAD, ABBOTT PARK, IL

Dipendente

114,000

Cinguettio

@AbbottNews

Prossima data di guadagno

2025-04-16

Ultimi documenti SEC

ABT's Discussions on Twitter

Confronta ABT con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ABT Abbott Laboratories	132.56	221.92B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	95.91	139.43B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	350.23	134.90B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	83.00	108.02B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	72.03	40.93B	5.72B	4.17B	259.90M	6.97

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-10-08	Iniziato	Oppenheimer	Outperform
2024-09-19	Iniziato	Piper Sandler	Overweight
2024-07-30	Downgrade	Edward Jones	Buy → Hold
2024-05-30	Iniziato	Goldman	Buy
2023-07-21	Aggiornamento	Wolfe Research	Underperform → Peer Perform
2023-05-30	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2023-04-20	Reiterato	Barclays	Overweight
2023-04-20	Reiterato	Bernstein	Outperform
2023-04-20	Reiterato	JP Morgan	Overweight
2023-04-20	Reiterato	Raymond James	Outperform
2023-04-20	Reiterato	UBS	Buy
2023-04-20	Reiterato	Wolfe Research	Underperform
2023-03-29	Iniziato	UBS	Buy
2022-10-26	Iniziato	Mizuho	Neutral
2022-10-18	Iniziato	Barclays	Overweight
2022-10-12	Iniziato	Jefferies	Hold
2022-07-06	Iniziato	Wolfe Research	Underperform
2022-03-02	Ripresa	BofA Securities	Buy
2022-01-27	Reiterato	Credit Suisse	Outperform
2022-01-27	Reiterato	Morgan Stanley	Overweight
2022-01-27	Reiterato	Raymond James	Outperform
2022-01-27	Reiterato	UBS	Buy
2021-12-10	Iniziato	RBC Capital Mkts	Outperform
2021-10-27	Aggiornamento	Atlantic Equities	Neutral → Overweight
2021-10-14	Iniziato	Redburn	Neutral
2021-05-25	Iniziato	Barclays	Overweight
2021-04-15	Iniziato	Atlantic Equities	Neutral
2021-01-28	Aggiornamento	BTIG Research	Neutral → Buy
2020-09-11	Iniziato	Wolfe Research	Outperform
2020-06-01	Downgrade	Goldman	Neutral → Sell
2020-03-05	Iniziato	Citigroup	Buy
2020-02-13	Iniziato	Goldman	Neutral
2020-02-06	Ripresa	BTIG Research	Neutral
2020-01-02	Downgrade	Guggenheim	Buy → Neutral
2019-06-13	Reiterato	BofA/Merrill	Buy
2019-02-07	Reiterato	BofA/Merrill	Buy
2019-01-02	Downgrade	Citigroup	Neutral → Sell
2018-11-30	Aggiornamento	Goldman	Neutral → Buy
2018-10-16	Iniziato	Barclays	Overweight
2018-06-27	Iniziato	Bernstein	Outperform
2018-01-30	Reiterato	Citigroup	Neutral
2018-01-25	Reiterato	Stifel	Buy
2018-01-25	Aggiornamento	William Blair	Mkt Perform → Outperform
2018-01-03	Iniziato	Evercore ISI	Outperform
2018-01-02	Aggiornamento	JP Morgan	Neutral → Overweight
2018-01-02	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2017-10-19	Reiterato	RBC Capital Mkts	Outperform
2017-10-19	Reiterato	Stifel	Buy

Mostra tutto

Abbott Laboratories Borsa (ABT) Ultime notizie

01:01 AM

RBC Capital lifts Abbott Labs target to $145, maintains Outperform By Investing.com - Investing.com India

01:01 AM

TD Cowen lifts Abbott stock price target to $145, maintains Buy rating - Investing.com India

01:01 AM

12:50 PM

Abbott Labs stock target raised to $144 by Bernstein SocGen - Investing.com UK

12:50 PM

12:26 PM

RBC Capital lifts Abbott Labs target to $145, maintains Outperform - Investing.com

12:26 PM

12:01 PM

UBS maintains Buy on Abbott Labs with $148 price target By Investing.com - Investing.com India

12:01 PM

11:45 AM

Abbott Labs (ABT) Stock: Earnings Beat with Strong MedTech Growth and $500M U.S. Investment - CoinCentral

11:45 AM

11:11 AM

These Analysts Boost Their Forecasts On Abbott Laboratories After Better-Than-Expected Earnings - Benzinga

11:11 AM

11:02 AM

Piper Sandler raises Abbott Labs target to $145, keeps Overweight By Investing.com - Investing.com India

11:02 AM

11:00 AM

Drug Screening Market Size Worth USD 10.34 Billion by 2034 | CAGR of 4.84% from 2025 to 2034 - GlobeNewswire Inc.

11:00 AM

10:51 AM

Piper Sandler raises Abbott Labs target to $145, keeps Overweight - Investing.com

10:51 AM

10:28 AM

Citi Reaffirms Their Buy Rating on Abbott Laboratories (ABT) - The Globe and Mail

10:28 AM

10:00 AM

Demystifying Abbott Laboratories: Insights From 11 Analyst Reviews - Benzinga

10:00 AM

09:01 AM

RBC Capital Increases Price Target for Abbott (ABT) to $145 | ABT Stock News - GuruFocus

09:01 AM

09:00 AM

Stifel cuts Abbott Labs stock target to $135, maintains buy rating - Investing.com India

09:00 AM

08:37 AM

Abbott Laboratories: Strong Performance and Strategic Positioning Drive Buy Rating - TipRanks

08:37 AM

08:21 AM

Oppenheimer Increases Price Target for Abbott (ABT) to $140 | ABT Stock News - GuruFocus

08:21 AM

08:20 AM